Health and Fitness

Credit: Unsplash/CC0 Public Domain Islet transplantation significantly reduces the risk of transplantation failure and enhances life expectancy in individuals with type 1 diabetes who undergo kidney transplantation, a new study has revealed. This breakthrough research, presented at the European Society for Organ Transplantation (ESOT) Congress 2023, compared the long-term outcomes of patients with type 1 …

Islet transplantation boosts long-term survival in kidney transplant recipients with type 1 diabetes Read More »

Credit: Pixabay/CC0 Public Domain New research, presented at the European Society for Organ Transplantation (ESOT) Congress 2023, demonstrates that neonatal kidney transplantation can offer a ‘game-changing’ solution to the pressing organ shortage crisis. To assess the feasibility of neonatal organ donation, researchers analyzed neonatal mortality in the United States and the long-term development of these …

Neonatal kidney transplantation offers new hope in the organ shortage crisis, study shows Read More »

NAM does not impact activation-induced cleavage of CD62L. NK cells enriched from the peripheral blood of 4 healthy donors were cultured overnight in the indicated culture conditions. Cells were then collected and analyzed by flow cytometry to assess surface CD16 and CD62L. Shown are representative flow cytometry plots (top) and cumulative data from all 4 …

Can a vitamin transform natural killer cells into a cancer therapy? Scientists think the answer is yes Read More »

If you have a Chuckle & Roar Ultimate Water Beads Activity Kit, a child’s toy made by Buffalo Games and sold exclusively at Target, throw it out. The toy is being recalled due to serious ingestion, choking and obstruction hazards after one infant died and another was injured and required surgery. Together, the U.S. Consumer …

Choking hazard spurs recall of bath toys sold at target Read More »

Credit: Pixabay/CC0 Public Domain Moderna has developed a new and improved version of its COVID-19 vaccine. The unique formulation (mRNA-1283) reduces the vaccine’s content from the full-length SARS-CoV-2 spike protein to a narrowly focused encoding of just two segments—the N-terminal domain (NTD) and the receptor binding domain (RBD). In a paper, “Domain-based mRNA vaccines encoding …

Moderna reveals new highly targeted COVID-19 vaccine mRNA-1283 Read More »

10 May 2023 | 09:59 AM Europe/Amsterdam Not intended for U.S. and UK Media Summary Global phase III QUASAR study will assess the efficacy and safety of aflibercept 8 mg in macular edema secondary to retinal vein occlusion (RVO) / Study comes after positive data from the phase III PULSAR trial in neovascular (wet) age-related …

Bayer initiates phase III study to investigate aflibercept 8 mg in retinal vein occlusion Read More »

Leverkusen/Kyiv, April 5, 2023 – Bayer has revealed an investment of overall 60 million euros from 2023 onwards in its corn seed production facility Pochuiky, Ukraine. With this the life sciences company emphasizes its commitment to Ukraine and strengthens its Crop Science business in the country, contributing to rebuilding the economy. This investment includes a …

Bayer to invest a total of 60 million euros in its Ukrainian seed production site Read More »

Leverkusen, April 3, 2023 – Bayer AG has established a Bioethics Council consisting of internationally renowned experts, to provide broad independent perspective and guidance on current bioethical questions, particularly with regard to the development of new biotechnological and artificial intelligence based solutions. Bayer is committed to using emerging technologies in an ethically responsible way as …

Bayer establishes Bioethics Council Read More »

Leverkusen, March 21, 2023 – Bayer is launching its new water strategy at the UN 2023 Water Conference in New York. The company is making water an integral part of its business decisions, investments and selection of suppliers. Bayer’s water strategy reflects its position as a key player in the fields of health and agriculture …

Bayer pledges to help tackle global water crisis with new water strategy Read More »

Not intended for U.S. and UK Media Berlin, March 20, 2023 – The Chinese National Medical Products Administration (NMPA) has approved the oral androgen receptor inhibitor (ARi) Nubeqa™ (darolutamide) in combination with docetaxel for the treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC). Nubeqa is already approved in China for the treatment of patients …

Nubeqa™ (darolutamide) approved for additional prostate cancer indication in China Read More »